article thumbnail

EMA pilot will see if clinical trial data should be digested ‘raw’

pharmaphorum

A pilot study has been launched by the EMA to see whether it is helpful for regulators to look at the ‘raw data’ from clinical trials submitted in support of new marketing application along with the usual structured analyses from sponsors. It may also help the regulator to define target treatment populations better.

article thumbnail

The DDW Podcast: 2023 in review

Drug Discovery World

In this episode, Kelland shares what she means by the ‘next pandemic’, the lessons learnt from the Covid-19 pandemic, and the role of global health organisations and pharma companies going forward. A deep dive into US drug discovery What lies in the future for genomics and big data? Listen here.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

How digital innovation is helping therapeutics to get to market faster

Drug Discovery World

Technologies like artificial intelligence (AI), machine learning (ML) and robotics/automation are enabling researchers to process enormous data sets and conduct preclinical investigations in record time, speeding up the process and offering greater accuracy. AI brings exciting opportunities to generate new insights and improve processes.

article thumbnail

Creating an effective patient engagement set of practices that is enduring and future-proof

pharmaphorum

The ‘PEP Talks’ monthly e-newsletter has approaching 50 pharma companies as subscribers and the inaugural ‘Patient Engagement Day’ on September 01 st achieved an inspirational number of downloads of toolkits for ways to ‘Amplify the Patient Voice’ as the launch theme. Will pharma listen, and is this even their role to do so?

article thumbnail

4 principles for the future of pharma marketing

pharmaphorum

They had to be nurtured and cared for, despite the fact we, as pharma companies, have very limited direct access to patients. ” What is different is that today we share cloud-based infrastructure and tools with non-pharma companies, like FMCG. Pharma has been successful because the environment is so regulated.

Marketing 107
article thumbnail

Ep. 002 – John Mack Podcast Transcript

Pharma Marketing Network

And when you look through who those Twitter followers are, it’s very heavily skewed towards industry, as is the website, we’ve also put some tools on our website to be able to look at who the visitors are, by company. Don Langsdorf (EHS): 141 different pharma companies from around the world. John Mack (PG): Yeah.